Stage FocusSeed, Series A
GeographyEurope, US
TypeVC
Last Activity2025
Industry Focus
Industries
BiotechMedtech
Technical BenchStrong
Investor TypeDeepTech Purist
ExposureMostly DeepTech Investments
Bio
Seroba Life Sciences is a European life sciences VC headquartered in Dublin, with Fund IV closed at €123M in February 2024. The fund targets up to 12 investments per vintage, with 5 already made including Perfuze, Sibylla Biotech, Deciphex, Complement Therapeutics, and Artica. The latest investment is Azafaros' Series B in May 2025, bringing total investments to 50.
The LP base reads like a who's...
Notable Investments
P
PerfuzeS
Sibylla BiotechD
DeciphexC
Complement TherapeuticsA
Artica TherapeuticsA
AzafarosSimilar Funds
AL
Advent Life Sciences
London, United Kingdom
Pure DeepTechBiotechMedtechSeedSeries A
FH
Fountain Healthcare Partners
Dublin, Ireland
Pure DeepTechBiotechMedtechRoboticsSeedSeries A
+C
+ND Capital
Woodside, CA, United States
Pure DeepTechBiotechAdvanced MaterialsSemiconductorsSeedSeries A
Versant Ventures
San Francisco, United States
Pure DeepTechBiotechMedtechSeedSeries A
3B
3E Bioventures Capital
China
Pure DeepTechBiotechMedtechSeedSeries A
5H
5 Horizons Ventures
Oklahoma City, United States
Pure DeepTechBiotechSeedSeries A